Aaron Chung

CATUG Biotechnology

BIOGRAPHY

Aaron Chung drives global expansion for CATUG Biotechnology's mRNA CDMO platform, focusing on end-to-end CMC development and IND-enabling capabilities for mRNA therapeutics. The platform spans process development, GMP manufacturing, and regulatory readiness to support clients across the full mRNA lifecycle.

Aaron previously founded and led Spindle Biotech Inc. before its acquisition by Applied DNA Sciences (NASDAQ: APDN), where he subsequently served as the Nucleic Acid Platform Director. He brings deep expertise in RNA and mRNA process development, manufacturing scale-up, and advancing biotech innovation from R&D to commercialization.